Company / Operating Cash Flow
MESA LABORATORIES INC /CO/ Operating Cash Flow History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$42.8M
FY2025
5-year range
$28.0M / $46.8M
FY2021-FY2025
Trend
-8.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 9 years, ranging from $26M in FY2017 to $47M in FY2024.
Based on SEC 10-K filings.
$43M in FY2025 with a 5-year CAGR of +2.9%.
Improved from $37M to $43M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +15.2%
- 5-Year CAGR
- +2.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +2.9%, indicating consistent growth.
- In FY2025, operating cash flow decreased 8.5% year-over-year.
- Peak operating cash flow was recorded in FY2024.
- Lowest operating cash flow in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.03 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | $42.8M | -8.5% |
| FY2024 | $46.8M | +26.3% |
| FY2023 | $37.1M | +32.5% |
| FY2022 | $28.0M | -28.7% |
| FY2021 | $39.2M | +5.8% |
| FY2020 | $37.1M | +37.4% |
| FY2019 | $27.0M | -11.7% |
| FY2018 | $30.6M | +18.8% |
| FY2017 | $25.7M | +48.6% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026